2024-09-25 - Analysis Report
## Thermo Fisher Scientific Inc. (TMO) Stock Analysis Report

**Company Overview:** Thermo Fisher Scientific Inc. is a leading provider of scientific instruments, consumables, and services for research, analysis, diagnostics, and production in the life sciences and pharmaceutical industries.

**Performance Analysis:**

1. **Performance vs. S&P 500:**  TMO has significantly outperformed the S&P 500 (VOO) with a cumulative return of 249.92% compared to VOO's 133.37%. This translates to a 116.55% difference, placing it at the 53.77th percentile of its historical performance range.

2. **Recent Price Movement:**
    - **Closing Price:** 610.4
    - **5-day Moving Average:** 612.86
    - **20-day Moving Average:** 613.21
    - **60-day Moving Average:** 590.52
    TMO's recent price movement suggests slight consolidation, trading above all three moving averages.

3. **Technical Indicators:**
    - **RSI:** 48.78 (Neutral)
    - **PPO:** -0.24 (Slightly Bearish)
    - **Delta_Previous_Relative_Divergence:** -1.07 (Short-term Downward Trend)
    - **Expected Return:** 30.537% (5-year estimated return on investment)
The technical indicators show mixed signals. The RSI suggests neutral sentiment, while the PPO hints at slight bearish pressure. The negative Delta_Previous_Relative_Divergence indicates a short-term downward trend. However, the high expected return could be a positive factor.

4. **Recent Earnings and Outlook:**
    | Date | EPS | Revenue |
    |---|---|---|
    | 2024-08-02 | 4.05 | 10.54 B$ | 
    | 2024-05-03 | 3.47 | 10.35 B$ |
    | 2023-11-03 | 4.44 | 10.57 B$ |
    | 2023-08-04 | 3.53 | 10.69 B$ |
    | 2024-08-02 | 3.53 | 10.69 B$ |
    *Note: The most recent earnings (2024-08-02) were slightly above analyst expectations.*
TMO's recent earnings have been consistently strong, indicating a healthy growth trajectory. The most recent earnings exceeded analyst expectations, which is positive. The company's focus on innovative products and services positions it well for continued growth in the future.

5. **News and Recent Issues:**
    * **Recent Market Outlook:** Thermo Fisher Scientific is seen as a strong player in the life sciences and diagnostics industry. Analysts anticipate continued growth driven by investments in research and development, acquisitions, and expanding into new markets.
    * **Analyst Opinions:** Most analysts maintain a "Buy" or "Outperform" rating on TMO, citing its strong fundamentals, consistent earnings growth, and attractive dividend yield.
    * **Performance Highlights:**  TMO has consistently outperformed its peers and the overall market in recent years, and its robust growth trajectory is expected to continue.

**Overall Analysis:**

Thermo Fisher Scientific Inc. (TMO) is a strong performer with a history of outperforming the market. Its recent earnings have been consistently strong, and the company is well-positioned for continued growth. While the technical indicators show mixed signals, the high expected return and strong fundamentals make it an attractive investment opportunity. 

**Disclaimer:** This analysis is based on publicly available information and should not be considered financial advice. Always conduct your own research before making any investment decisions.